Mayank Mamtani

Feb 23, 2026

On Feb 23, 2026, NKTR was given a Buy rating by Mayank Mamtani, with a target price of 150. Despite the Buy call, shares fell from 68.11 to 68.11, challenging the optimistic stance.

Jan 21, 2026

CYTK received a Buy rating from Mayank Mamtani on Jan 21, 2026, aiming for 108. Price action was muted, as shares hovered around 60.72 despite the bullish outlook.

Dec 10, 2025

On Dec 10, 2025, Mayank Mamtani published a Buy outlook on IRD, with a target of 9. Shares gained 70.00%, underscoring the accuracy of the bullish outlook toward 9.

Dec 01, 2025

Mayank Mamtani on Dec 01, 2025 assigned CNTA a Buy rating, with a price target of 42. The call has struggled to gain traction, with shares losing 7.97%.

Nov 21, 2025

On Nov 21, 2025, Mayank Mamtani reaffirmed ZYME with a Buy rating, targeting 40. Market indecision has kept the 40 target in a holding pattern.

Nov 19, 2025

NUVB was rated Buy by Mayank Mamtani on Nov 19, 2025, with a price objective of 12. This case shows how bullish projections can fail, with the stock now below 4.36.

Nov 10, 2025

On Nov 10, 2025, Mayank Mamtani initiated coverage on NVAX with a Buy rating and target of 16. The stock’s climb of 33.47% since the call highlights the foresight in the rating.

Oct 01, 2025

Mayank Mamtani issued a Buy recommendation for HROW on Oct 01, 2025, price target set at 74. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Sep 29, 2025

On Sep 29, 2025, MDGL was evaluated by Mayank Mamtani, who gave a Buy rating and target of 560. So far, the Buy call awaits clearer momentum, with shares flat at 425.85.

Sep 17, 2025

Mayank Mamtani rated TGTX as Buy on Sep 17, 2025, setting a price target of 55. The stock has underperformed, dropping 9.86% despite the bullish target of 55.

Aug 26, 2025

On Aug 26, 2025, ACTU was given a Buy rating by Mayank Mamtani, with a target price of 20. Despite the Buy call, shares fell from 3.06 to 3.06, challenging the optimistic stance.

Aug 13, 2025

ALT received a Buy rating from Mayank Mamtani on Aug 13, 2025, aiming for 18. Momentum has favored the Buy call, with shares climbing from 4.16 to 4.16, rewarding those who trusted the recommendation.

Jun 16, 2025

On Jun 16, 2025, Mayank Mamtani published a Buy outlook on MNOV, with a target of 5. Shares gained 6.02%, underscoring the accuracy of the bullish outlook toward 5.

Mar 27, 2025

On Mar 27, 2025, Mayank Mamtani reaffirmed VXRT with a Buy rating, targeting 2. The recommendation was supported by strong follow-through as the stock rose from 0.75 to 0.75.

Mar 19, 2025

TRVI was rated Buy by Mayank Mamtani on Mar 19, 2025, with a price objective of 20. A bullish response from the market helped close the gap of 7.74 to the target.

Mar 14, 2025

On Mar 14, 2025, Mayank Mamtani initiated coverage on LCTX with a Buy rating and target of 3. The stock’s climb of 263.46% since the call highlights the foresight in the rating.

Mar 05, 2025

Mayank Mamtani issued a Buy recommendation for DNLI on Mar 05, 2025, price target set at 35. Investors following the Buy call captured upside momentum, with shares now at 20.02.

Feb 14, 2025

On Feb 14, 2025, ARWR was evaluated by Mayank Mamtani, who gave a Buy rating and target of 38. This case illustrates how a timely bullish rating can translate into tangible gains of 221.30%.

Feb 07, 2025

Mayank Mamtani rated VKTX as Buy on Feb 07, 2025, setting a price target of 96. Shares have remained stable near 31.93, leaving the 96 target still in play.

Dec 19, 2024

On Dec 19, 2024, CGTX was given a Buy rating by Mayank Mamtani, with a target price of 1.5. The stock rallied 60.88% after the rating, narrowing the gap to the target of 1.5 and validating the bullish stance.